The Scientist

» IP

Most Recent

image: Week in Review: August 29–September 2

Week in Review: August 29–September 2

By | September 2, 2016

Roger Tsien dies; the CRISPR patent dispute you’ve never heard of; immunotherapy for Alzheimer’s; Tasmanian devils developing resistance to transmissible cancer

0 Comments

image: Do Patents Promote or Stall Innovation?

Do Patents Promote or Stall Innovation?

By | June 1, 2016

A petition recently filed with the Supreme Court triggers renewed debate about the role of patents in the diagnostics sector.

3 Comments

image: “Heroes of CRISPR” Disputed

“Heroes of CRISPR” Disputed

By | January 19, 2016

Critics have harsh words for the Broad Institute’s Eric Lander and Cell over a recent perspective piece describing the history of CRISPR.

10 Comments

image: Opinion: Translation Nation

Opinion: Translation Nation

By | November 18, 2015

What’s in store for commercialization grants at the Canadian Institutes of Health Research?

0 Comments

image: <em>TS</em> Picks: January 29, 2014

TS Picks: January 29, 2014

By | January 29, 2015

Celebrating lab techs; Myriad settles suits; publish in top-tier journals or perish

0 Comments

image: Keeping Up with IP

Keeping Up with IP

By | September 1, 2014

It’s never too early to start thinking about intellectual property rights—even for biologists doing basic research.

0 Comments

image: Yet Another Lawsuit over Genetic Tests

Yet Another Lawsuit over Genetic Tests

By | June 17, 2014

Myriad Genetics, the company originally behind tests for the cancer-associated BRCA mutations, is suing another competitor for patent infringement.

0 Comments

image: Week in Review: August 19–23

Week in Review: August 19–23

By | August 23, 2013

The importance of smORFs; America Invents Act and innovation in biotech; birds adjust their behavior to avoid cars; in defense of fundamental science

0 Comments

image: Opinion: AIA Does Not Discriminate

Opinion: AIA Does Not Discriminate

By | August 21, 2013

The America Invents Act (AIA) was a step in the right direction for US competitiveness and open innovation.

5 Comments

image: Medicines for the World

Medicines for the World

By | October 1, 2012

A global R&D treaty could boost innovation and improve the health of the world’s poor—and rich.

0 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. Does Productivity Diminish Research Quality?
  3. How Plants Evolved Different Ways to Make Caffeine
  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech